XTL Biopharmaceuticals Ltd.
Cash Flow
Last updated:
Cash flow statement presents a set of outflows and inflows of cash within a company through operating, investing and financing activities. Over the last year, operating activities of XTL Biopharmaceuticals Ltd. generated cash of -$707,000, which is more than the previous year. Cash used in financing activities reached the amount of $0 last year. Net change in cash is therefore -$693,000.
Cash Flow
| 2014 | -2.47M | 1.49M | 309K |
|---|---|---|---|
| 2015 | -1.86M | -110K | 3.57M |
| 2016 | -1.73M | -66K | 0 |
| 2017 | -1.12M | -2.49M | 4.89M |
| 2018 | -816K | 778K | 0 |
| 2019 | -908K | 2.11M | 0 |
| 2020 | -850K | 32K | 0 |
| 2021 | -1.04M | 8K | 385K |
| 2022 | -901K | 36K | 0 |
| 2023 | -707K | 41K | 0 |
XTLB Cash Flow Statement (2014 – 2023)
| 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | |
|---|---|---|---|---|---|---|---|---|---|---|
Cash at beginning of period | 2.09M | 2.96M | 3.63M | 4.45M | 3.25M | 3.28M | 2.01M | 3.81M | 2.15M | 2.88M |
Operating activities | ||||||||||
Net income | -1.78M | -1.34M | 435K | -782K | -1.34M | 2.98M | -781K | -2.54M | -4.31M | -2.86M |
| Adjustments to reconcile net income to cash generated by operating activities: | ||||||||||
Depreciation and amortization | 0 | 1K | 1K | 1K | 0 | 0 | 1K | 3K | 7K | 53K |
Stock-based compensation expense | 3K | 14K | 37K | 51K | 5K | 0 | 40K | 182K | 148K | 278K |
| Deferred income tax benefit | 3K | 14K | 37K | 51K | 5K | 0 | 40K | 182K | 148K | 278K |
| Changes in operating assets and liabilities: | ||||||||||
Accounts receivable, net | 0 | 0 | 0 | 0 | 0 | 39K | 209K | -114K | 36K | 58K |
Inventories | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 184K |
Accounts payable | 19K | -44K | -23K | 22K | -21K | -47K | -13K | -101K | -117K | -210K |
Cash generated by operating activities | -707K | -901K | -1.04M | -850K | -908K | -816K | -1.12M | -1.73M | -1.86M | -2.47M |
Investing activities | ||||||||||
Purchases Of Investments | 0 | 0 | 0 | 0 | 0 | -6.3M | -2.5M | 0 | -10K | 0 |
Investments In Property Plant And Equipment | 0 | 0 | 0 | -1K | -2K | 0 | 0 | -66K | -66K | -10K |
Acquisitions Net | 0 | 0 | 0 | 0 | 0 | 0 | 1K | 0 | -55K | 0 |
Cash generated by investing activities | 41K | 36K | 8K | 32K | 2.11M | 778K | -2.49M | -66K | -110K | 1.49M |
Financing activities | ||||||||||
Common Stock Issued | 0 | 0 | 385K | 0 | 0 | 0 | 4.89M | 0 | 3.55M | 309K |
Payments for dividends | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Repurchases of common stock | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Repayments of term debt | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Cash used in financing activities | 0 | 0 | 385K | 0 | 0 | 0 | 4.89M | 0 | 3.57M | 309K |
Net Change In Cash | -693K | -875K | -662K | -824K | 1.2M | -34K | 1.27M | -1.79M | 1.65M | -728K |
Cash at end of period | 1.40M | 2.09M | 2.96M | 3.63M | 4.45M | 3.25M | 3.28M | 2.01M | 3.81M | 2.15M |
| Data source | Data source | Data source | Data source | Data source | Data source | Data source | Data source | Data source | Data source |